Daiwa Securities Group’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
Daiwa Securities Group's ADPT Position: Q1 2026 in Review
Daiwa Securities Group sold out of Adaptive Biotechnologies (ADPT) in Q1 2026, closing a stake of 430 shares — an estimated $7K sold.
Daiwa Securities Group first reported a position in ADPT in Q4 2019 and held it in 25 quarters. The position peaked at $35K in Q3 2020. 298 funds tracked by Wall St. Rank hold ADPT as of Q1 2026.
- Daiwa Securities Group reported no remaining Adaptive Biotechnologies position as of Q1 2026 after selling out during the quarter.
- Daiwa Securities Group sold 430 Adaptive Biotechnologies shares in Q1 2026, an estimated $7K.
- Daiwa Securities Group first reported a position in Adaptive Biotechnologies in Q4 2019 and held it in 25 quarters.
- Daiwa Securities Group's Adaptive Biotechnologies position peaked at $35K in Q3 2020.
- 298 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2026.
Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.